POC Blood Gas and Electrolyte Market is expected to grow at a CAGR of 7.8% by 2023 with estimated to cross USD 2,543.1 million
Point of care blood gas and electrolyte analyzers is the new technology, which helps in reducing therapeutic turnaround time, enhancing patient satisfaction, accuracy, and help to improve hospital operations.
(EMAILWIRE.COM, January 18, 2018 ) Rising prevalence of chronic diseases and cancer across the globe, increasing the treatment of NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department, which drives the global point of care blood gas and electrolyte devices market growth. In 2017, due to changes in the regulatory policies of the U.S., R&D investment is affected to some extent. In 2016, R&D spending of the US was 527.5 billion, which grew by 1.6% in 2017. Currently, the major shares of the global market are dominated by few leading players, and they can fluctuate the costs of the products. In developing regions such as Asia Pacific the suppliers are trying to provide their products at affordable price.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/5085 .
Regional Analysis
The Americas dominate the global market owing to a huge population with chronic diseases such as diabetes, kidney, and liver disease, increasing government support for research & development, and high health care expenditure. According to the WHO, in 2014, 9.7% of the total America population is having diabetes. Thus, increasing prevalence of diabetes has boosted the market growth. Additionally, changing lifestyle and the presence of major players in the market have fuelled the growth of the market.
Europe is the second largest point of care devices market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market and majorly driven by India and China owing to a huge number patients with chronic diseases and rapidly growing economy. According to the WHO, 60% of the global diabetic population lives in Asia Pacific region. The healthcare expenditure of Asia Pacific has increased over the last few years, which has contributed to the growth of the market.
The Middle East and Africa region account for the least share of the global market. Whereas, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region.
Key Players
Some of the major players in this market: Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory
Browse complete report at https://www.marketresearchfuture.com/reports/poc-blood-gas-and-electrolyte-market-5085 .
The global point of care blood gas and electrolyte gas devices market has been segmented on the basis of types and end users.
On the basis of the types, the market is segmented into consumables and Instruments. The instrument type is sub-segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, home care, research institutions, and others.
Point of care blood gas and electrolyte devices are used majorly in the area of hospitals where patients are being ventilated. Increase in the treatments in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department has boosted the point of care blood gas and electrolyte devices market growth. Additionally, rising prevalence of chronic diseases and cancer fuels the market growth.
According to the Centers for Disease Control and Prevention, in 2015, the number of adults with diagnosed chronic bronchitis and emphysema were 9.3 million and 3.5 million respectively. Additionally, according to WHO in 2016, over 1.9 billion adults aged 18 years and older were obese, which was approximately 650 million. Overall 13% of world’s adult population (11% of men and 15% of women) were obese. These diseases are the main cause of the immense growth of treatment in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department. Point of care blood gas developers is now focusing on developing automated and user-friendly devices, which may lead the market of this product in the coming future. Healthcare expenditure across the world is rapidly increasing. From the last decade, healthcare expenditure in regions like the Americas and Europe has been growing rapidly. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending was increased by 5.8% and reached USD 3.2 trillion.
Ask Question to Expert at https://www.marketresearchfuture.com/enquiry/5085 .
Key Findings:
Consumables product segment accounts for the largest market share of 61.5% while the instruments segment is projected to grow at a CAGR of 6.3% during the forecast period from 2017 – 2023
Hospitals & clinics dominates the global POC blood gas and electrolyte market with nearly 58.4% share of the global market, by end users
Americas POC blood gas and electrolyte market is estimated to be USD 600.2 million in 2016
Europe is the second largest market, which is followed by Asia Pacific owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure. Regionally, Europe is divided into Germany, France, the U.K, Italy, Spain, and Rest of Western Europe. Germany and the U.K are the major contributors to the European market growth.
Asia Pacific is also witnessing a rapid growth in this market due to rapidly increasing diabetic & obese population and rising healthcare expenditure. According to the WHO, 60% of world’s total diabetic population lives in Asia Pacific region. Additionally, the presence of rapidly developing economies like India and China likely to fuel the market growth over the forecast period.
The Middle East & Africa hold the least share of the market due to poor political conditions in Africa, and limited availability of funds and medical facilities. The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries like Kuwait, Qatar, Oman, and Saudi Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market during the review period.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/5085 .
Regional Analysis
The Americas dominate the global market owing to a huge population with chronic diseases such as diabetes, kidney, and liver disease, increasing government support for research & development, and high health care expenditure. According to the WHO, in 2014, 9.7% of the total America population is having diabetes. Thus, increasing prevalence of diabetes has boosted the market growth. Additionally, changing lifestyle and the presence of major players in the market have fuelled the growth of the market.
Europe is the second largest point of care devices market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market and majorly driven by India and China owing to a huge number patients with chronic diseases and rapidly growing economy. According to the WHO, 60% of the global diabetic population lives in Asia Pacific region. The healthcare expenditure of Asia Pacific has increased over the last few years, which has contributed to the growth of the market.
The Middle East and Africa region account for the least share of the global market. Whereas, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region.
Key Players
Some of the major players in this market: Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory
Browse complete report at https://www.marketresearchfuture.com/reports/poc-blood-gas-and-electrolyte-market-5085 .
The global point of care blood gas and electrolyte gas devices market has been segmented on the basis of types and end users.
On the basis of the types, the market is segmented into consumables and Instruments. The instrument type is sub-segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, home care, research institutions, and others.
Point of care blood gas and electrolyte devices are used majorly in the area of hospitals where patients are being ventilated. Increase in the treatments in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department has boosted the point of care blood gas and electrolyte devices market growth. Additionally, rising prevalence of chronic diseases and cancer fuels the market growth.
According to the Centers for Disease Control and Prevention, in 2015, the number of adults with diagnosed chronic bronchitis and emphysema were 9.3 million and 3.5 million respectively. Additionally, according to WHO in 2016, over 1.9 billion adults aged 18 years and older were obese, which was approximately 650 million. Overall 13% of world’s adult population (11% of men and 15% of women) were obese. These diseases are the main cause of the immense growth of treatment in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department. Point of care blood gas developers is now focusing on developing automated and user-friendly devices, which may lead the market of this product in the coming future. Healthcare expenditure across the world is rapidly increasing. From the last decade, healthcare expenditure in regions like the Americas and Europe has been growing rapidly. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending was increased by 5.8% and reached USD 3.2 trillion.
Ask Question to Expert at https://www.marketresearchfuture.com/enquiry/5085 .
Key Findings:
Consumables product segment accounts for the largest market share of 61.5% while the instruments segment is projected to grow at a CAGR of 6.3% during the forecast period from 2017 – 2023
Hospitals & clinics dominates the global POC blood gas and electrolyte market with nearly 58.4% share of the global market, by end users
Americas POC blood gas and electrolyte market is estimated to be USD 600.2 million in 2016
Europe is the second largest market, which is followed by Asia Pacific owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure. Regionally, Europe is divided into Germany, France, the U.K, Italy, Spain, and Rest of Western Europe. Germany and the U.K are the major contributors to the European market growth.
Asia Pacific is also witnessing a rapid growth in this market due to rapidly increasing diabetic & obese population and rising healthcare expenditure. According to the WHO, 60% of world’s total diabetic population lives in Asia Pacific region. Additionally, the presence of rapidly developing economies like India and China likely to fuel the market growth over the forecast period.
The Middle East & Africa hold the least share of the market due to poor political conditions in Africa, and limited availability of funds and medical facilities. The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries like Kuwait, Qatar, Oman, and Saudi Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market during the review period.
Contact Information:
Marketresearchfuture
Market Research Future
Tel: +1 (646) 845 9349
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Marketresearchfuture
Market Research Future
Tel: +1 (646) 845 9349
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results